Literature DB >> 29196929

Factors associated with calcium requirements after parathyroidectomy in chronic kidney disease patients.

Yue Ding1, Hongying Wang2, Qiang Zou1, Yiting Jin1, Zijing Zhang1, Junwen Huang1.   

Abstract

BACKGROUND: Renal hyperparathyroidism is a common complication of chronic kidney disease (CKD). Parathyroidectomy (PTX) for these patients continues to be a valuable option in the era of calcimimetics. Postoperative hypocalcemia is common after surgery. The aim of this study was to identify clinical factors to define postoperative calcium requirements.
METHODS: From February 2013 to May 2017, 68 patients with chronic kidney disease 5 (CKD5) who underwent PTX were reviewed. We collected clinical and laboratory data preoperatively and calculated the total calcium requirement in a week after surgery. Univariate and multiple analyses were performed to study whether these clinical and laboratory factors were associated with calcium requirement.
RESULTS: Univariate analysis showed that preoperative alkaline phosphatase (ALP), calcium (Ca), parathyroid hormone and hemoglobin were independently associated with calcium requirement. Multivariate model showed that the preoperative ALP was the only independent factor that could predict the requirement of calcium.
CONCLUSIONS: In the context of a high dCa (1.75 mmol/l) and a stable dose of calcitriol, preoperative ALP levels were significantly associated with calcium requirement in patients with CKD5 undergoing PTX.

Entities:  

Keywords:  Calcium requirements; Chronic kidney disease; Parathyroidectomy; Renal hyperparathyroidism

Mesh:

Substances:

Year:  2017        PMID: 29196929     DOI: 10.1007/s11255-017-1759-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  29 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  THE METABOLIC EFFECTS OF STEROID HORMONES IN OSTEOPOROSIS.

Authors:  E C Reifenstein; F Albright
Journal:  J Clin Invest       Date:  1947-01       Impact factor: 14.808

3.  Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea pigs.1 II. passive transfer of renal lesions by anti-tubular basement membrane autoantibody and nonimmune bone marrow cells to leukocyte-depleted recipients.

Authors:  U H Rudofsky; B Pollara
Journal:  Clin Immunol Immunopathol       Date:  1976-07

4.  New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.

Authors:  A Gal-Moscovici; M M Popovtzer
Journal:  Clin Nephrol       Date:  2005-04       Impact factor: 0.975

5.  An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism--the German perspective.

Authors:  Ralph Schneider; Georgios Kolios; Benjamin M Koch; Emilio Domínguez Fernández; Detlef K Bartsch; Katja Schlosser
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

6.  Are preoperative serum calcium, parathyroid hormone, and adenoma weight predictive of postoperative hypocalcemia?

Authors:  Pamela L Strickland; James Recabaren
Journal:  Am Surg       Date:  2002-12       Impact factor: 0.688

7.  Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.

Authors:  Elizabeth A Mittendorf; James I Merlino; Christopher R McHenry
Journal:  Am Surg       Date:  2004-02       Impact factor: 0.688

8.  Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.

Authors:  Rajeev Narayan; Robert M Perkins; Elizabeth P Berbano; Christina M Yuan; Robert T Neff; Eric S Sawyers; Fred E Yeo; Gwenaelle M Vidal-Trecan; Kevin C Abbott
Journal:  Am J Kidney Dis       Date:  2007-06       Impact factor: 8.860

9.  Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study.

Authors:  Pablo Ureña; Stefan H Jacobson; Emanuel Zitt; Marc Vervloet; Fabio Malberti; Neil Ashman; Sean Leavey; Marianne Rix; Ingrid Os; Heikki Saha; Miroslav Ryba; Veronika Bencova; Ana Baños; Valter Zani; Denis Fouque
Journal:  Nephrol Dial Transplant       Date:  2009-04-15       Impact factor: 5.992

10.  Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism.

Authors:  Lo-Yi Ho; Ping-Nam Wong; Ho-Kwan Sin; Yuk-Yi Wong; Kwok-Chi Lo; Shuk-Fan Chan; Man-Wai Lo; Kin-Yee Lo; Siu-Ka Mak; Andrew Kui-Man Wong
Journal:  BMC Nephrol       Date:  2017-01-10       Impact factor: 2.388

View more
  1 in total

1.  Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis.

Authors:  Dan Gao; Yan Lou; Yingchun Cui; Shengmao Liu; Wenpeng Cui; Guangdong Sun
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.